title: Clinical inquiries. What treatment approach to intrapartum maternal fever has the best fetal outcomes?
authors.affiliation: Eglin Air Force Base Family Medicine Residency, Eglin AFB, FL, USA.
authors.forename: Matthew
authors.initials: M
authors.lastname: Snyder
authors.forename: Paul
authors.initials: P
authors.lastname: Crawford
authors.forename: Barbara
authors.initials: B
authors.lastname: Jamieson
authors.forename: Jon O
authors.initials: JO
authors.lastname: Neher
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use; D000667:Ampicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002821:Chorioamnionitis / Q000188:drug therapy*; D002981:Clindamycin / Q000008:administration & dosage; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002981:Clindamycin; D000667:Ampicillin